brentuximab,Dacarbazine,Doxorubicin Hydrochloride,Filgrastim,Nivolumab,Pegfilgrastim,Vinblastine Sulfate
seagen,amgen,Bms
['lymphoma', 'nivo', 'brentuximab', ' vedo', 'hodgkin', 'nivolumab']
christine sadlowski and dr. michael williams talk to dr. alex herrera about second interim results of a study that show promise for using the pd-1 inhibitor nivolumab instead of brentuximab vedotin for advanced-stage, classic hodgkin's lymphoma. #asco23 
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.